Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

New standard listing: Ikigai Ventures seeks social impact deal

Aquis weekly movers: VVV Resources share price slump

AIM weekly movers: Potential Advance Energy reversal and Joules short of cash

AIM Movers: Light Science contract progress and AfriTin Mining funding

AIM movers: Tertiary Minerals technical deal and ex-dividends

Standard reversal: Critical Metals copper deal

Blackbird revenues grow

AIM movers: Naked Wines late night warning and ITM Power boss to depart

AIM movers: Tungsten West financing agreement and potential Transense licence

Earnings enhancing deal for Epwin

MP Evans dividend growth continues

AIM movers: UK Oil & Gas cash call and Greatland secures Havieron funding share

AIM dividends growing and some are highly attractive

Aquis weekly movers: Wishbone Gold share price dives after fundraising

AIM weekly movers: Potential reversal for Advance Energy

AIM movers: Libertine powertrain deal and Tlou Energy investigated by Australian authorities

Best of the Best international tie-up

AIM movers: Warpaint London surprises and AssetCo stake value increase

North America propels Somero Enterprises

Alien Metals cash call

AIM movers: GB Group bid approach and Arrow Exploration gas flow figures

AIM movers: Colombia drilling success for Orosur and large loss for Inland Homes

Why companies left AIM in August

Samarkand fundraising to cover losses

Belvoir lettings and financial services income grows

AIM movers: Oil and gas companies dominate risers

New standard listing: Zamaz online brand buildling plans

Aquis weekly movers: S-Ventures cash injection

AIM weekly movers: Diurnal more than doubles on bid

AIM movers: Shoe Zone buy back and Serinus Energy well disappoints

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020